ASEP Medical Holdings Inc. (CSE: ASEP)
Canada
· Delayed Price · Currency is CAD
0.0900
0.00 (0.00%)
Sep 25, 2024, 4:00 PM EDT
ASEP Medical Holdings Company Description
ASEP Medical Holdings Inc., together with its subsidiaries, focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis.
It offers peptide technology for therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and anti-fouling coating.
The company was formerly known as Trenchant Life Sciences Investment Corp. ASEP Medical Holdings Inc. was incorporated in 2020 and is headquartered in Victoria, Canada.
ASEP Medical Holdings Inc.
Country | Canada |
Founded | 2020 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 7 |
CEO | Robert E. Hancock |
Contact Details
Address: 730 View Street Victoria, British Columbia V8W 3Y7 Canada | |
Phone | 778-600-0509 |
Website | asepmedical.com |
Stock Details
Ticker Symbol | ASEP |
Exchange | Canadian Securities Exchange |
Fiscal Year | January - December |
Reporting Currency | CAD |
ISIN Number | CA04368A1057 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Dr. Robert E. W. Hancock FRSC, OC, Ph.D. | Founder, Chief Executive Officer and Executive Chairman |
Jacqueline M. Tucker F.C.A., FCPA | Chief Financial Officer |
Timothy W. Murphy | Chief Operating Officer, Corporate Secretary and Director |
Dr. Evan Haney | Chief Scientific Officer |
Dr. Fadia Saad M.B.A., Ph.D. | Chief Business Development Officer |